HAEVSLABT• 28 Days (Normalized)
HAE vs LABT (Haemonetics Corporation vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HAE Performance $104.68
+1.71%
Haemonetics Corporation
Normalized Baseline0.00%
LABT Performance $0.93
-50.39%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin HAE LEADS
+52.1 pts
HAE outperforming by 52.10 percentage points
HAELABT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HAE LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | HAE Price | HAE Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $104.68 | +1.71% | $0.93 | -50.39% | +52.10% |
| Oct 01, 2026 | $104.37 | +1.41% | $- | - | |
| Sep 30, 2026 | $105.30 | +2.31% | $- | - | |
| Sep 29, 2026 | $105.80 | +2.80% | $0.99 | -47.34% | +50.14% |
| Sep 28, 2026 | $105.79 | +2.79% | $1.15 | -38.83% | +41.62% |
| Sep 25, 2026 | $105.30 | +2.31% | $1.67 | -11.17% | +13.48% |
| Sep 24, 2026 | $- | $1.83 | -2.66% | - | |
| Sep 23, 2026 | $106.82 | +3.79% | $1.78 | -5.32% | +9.11% |
| Sep 22, 2026 | $108.52 | +5.44% | $1.99 | +5.85% | -0.41% |
| Sep 21, 2026 | $108.73 | +5.65% | $2.05 | +9.04% | -3.39% |
| Sep 18, 2026 | $108.40 | +5.32% | $1.99 | +5.85% | -0.53% |
| Sep 17, 2026 | $107.60 | +4.55% | $1.86 | -1.06% | +5.61% |
| Sep 16, 2026 | $106.24 | +3.23% | $2.09 | +11.17% | -7.94% |
| Sep 15, 2026 | $106.20 | +3.19% | $2.17 | +15.43% | -12.24% |
| Sep 14, 2026 | $106.31 | +3.29% | $2.12 | +12.77% | -9.48% |
Page 1 of 2